ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Toxicology Program Seeks Comment On Substances.

March 23, 2001

Tissue Bank Visibility Could Be Improved By Centralized Listing Of Resources: Panel

September 30, 1994